Dr. Athira Unnikrishnan, MD
901 W 38th St Ste 300, Austin, TX 78705 • +1-372-555-8365
Medical Education: Accredited U.S. Medical School (Class of 1999)
What This Doctor Actually Performs: CMS Medicare Utilization & Austin Percentiles
NPI #1467744391 • CBSA 12420 • Hematology-Oncology
CMS Medicare Part B utilization records credit Dr. Athira Unnikrishnan (MD, NPI 1467744391) at 901 W 38th St Ste 300 in Austin with 81,885 annual clinical services (569 beneficiaries), corresponding to a +0.02σ regional deviation and mid-cohort balanced caseload (36.36th Austin percentile) with sub-specialty concentration in 193 Active CMS HCPCS Codes.
Granular CPT/HCPCS billing distribution at 901 W 38th St Ste 300 shows Dr. Athira Unnikrishnan's primary concentration in Moderate-to-High Complexity Internal Medicine Follow-Up (code 99214: 3516x/yr, 36.36th local percentile) alongside Established Preventive & Chronic Care Visit (99213: 2031x/yr, $33–$48).
Cash-pay intake data for NPI 1467744391 (901 W 38th St Ste 300, Austin) indicates $211.00 typical out-of-pocket visit spend against a $211.00 locality benchmark, paired with 9-minute average reception wait and 4.44/5 biomarker openness.
Credentialed as an MD specialist with 27 years post-graduation experience since completing medical school at an LCME/COCA institution (1999), Dr. Unnikrishnan coordinates 193 Active CMS HCPCS Codes workups from 901 W 38th St Ste 300 (+1-372-555-8365).
Compared against Austin, TX Hematology-Oncology peers
81,885 annual services across 569 beneficiaries
Standard deviations from TX Hematology-Oncology mean utilization
Top Billed HCPCS/CPT Procedures & GPCI Self-Pay Cash Benchmarks
| HCPCS | Clinical Procedure Description | Annual Volume | Local Pct | Est. Cash Range |
|---|---|---|---|---|
| 99214 | Moderate-to-High Complexity Internal Medicine Follow-Up | 3,516 | 36.36th | $44 – $60 |
| 99213 | Established Preventive & Chronic Care Visit | 2,031 | 37.36th | $33 – $48 |
| 93000 | In-Office 12-Lead Resting Electrocardiogram | 1,016 | 39.36th | $25 – $40 |
| G0439 | Annual Preventive Wellness & Cardiometabolic Risk Assessment | 781 | 39.36th | $51 – $70 |
| 99204 | Comprehensive New Patient Internal Medicine Diagnostic Visit | 469 | 34.36th | $61 – $83 |
| 96372 | Therapeutic Subcutaneous/Intramuscular Injection Administration (193 HCPCS billing breadth) | 74,072 | 36.36th | $45 – $65 |
Are you Dr. Athira Unnikrishnan? Embed your Official DotMD Verification Badge (0-JS SVG)
Paste this lightweight SVG snippet onto your clinic bio page in Austin, TX:
<a href="https://dotmd.com/doctors/athira-unnikrishnan-md-austin-tx-1467744391" title="Dr. Athira Unnikrishnan, MD - Verified CMS Utilization on DotMD"><img src="https://dotmd.com/badges/npi/1467744391.svg" alt="Dr. Athira Unnikrishnan Hematology-Oncology Badge" width="280" height="72" /></a>
Dr. Athira Unnikrishnan, MD Fair Cash-Pay & Waiting-Room Scorecard
| Metric | Verified Benchmark | Source |
|---|---|---|
| Dr. Unnikrishnan National Provider Identifier | NPI #1467744391 (MD) | CMS NPPES Registry (78705) |
| Dr. Unnikrishnan Austin CMS Volume Rank | 36.36th Pct (81,885 CMS svcs; Z +0.018σ) | CMS Medicare Part B (TX Hematology-Oncology) |
| Fair Cash-Pay New-Patient Benchmark | $211.00 (CPT 99204 GPCI Benchmark) | CMS Geographic Practice Cost Index (Austin, TX) |
| Waiting-Room Wait Time & Cash Friendliness | $211.00 avg paid • 9 min lobby wait | 19 Anonymous Patient Reports |
| Listens Without Rushing & Modern Protocol Score | 4.69/5 Listening • 4.44/5 Modern Labs | CMS Provider Practice Cohort |
“Waiting Room” Patient Reality Scorecard
Ask our AI Specialists anything about Dr. Athira Unnikrishnan
Other High-Volume Hematology-Oncology Specialists in Austin, TX
Ranked strictly by CMS Medicare volumeDr. Unnikrishnan Waiting-Room Q&A & Patient Experience Logs
Anonymous patient-submitted wait times, cash visit fees, and bedside manner discussions in Austin, TX.
Share your self-pay visit cost and lobby wait time—no account, email, or IP stored.
Filter Dr. Athira Unnikrishnan community threads and patient logs by age, biological sex, dosage, and treatment duration.